Skip to main content

Omnicell Value Stock - Dividend - Research Selection


ISIN: US68213N1090 , WKN: 632313

Market price date:
Market price:  

Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Key figures
Cash flow
Balance sheet
Income statement
Div. Yield%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization USD
Raw Data Source
Stock Split

Description of the company

Omnicell, Inc. provides automation and business analytics software solutions for medication and supply management in healthcare worldwide. The company operates through two segments, Automation and Analytics, and Medication Adherence. It offers Omnicell Automated Dispensing Cabinets, a dispensing system, which automates the management and dispensing of medications; SinglePointe, a software product that controls medications; AnywhereRN, a software which remotely queue medications from automated dispensing cabinets; Omnicell Analytics and Pandora Analytics reporting and data analytics tools; and Anesthesia Workstation that manages anesthesia supplies and medications. The company also provides XR2 Central Pharmacy System, a hospital pharmacy robotics system; Central and Satellite Pharmacy Manager, an automated pharmacy storage and retrieval system; Controlled Substance Management, a controlled substance inventory management system; OmniLinkRx, a prescription routing system; and WorkflowRx, an automated pharmacy storage, retrieval, and packaging system. In addition, it offers Omnicell Supply Management System, an automated dispensing system; Omnicell Tissue Center, which manages the chain of custody for bone and tissue specimens; OptiFlex MS that manages medical and surgical supplies; OptiFlex SS, a module for the perioperative areas; and OptiFlex CL, a module for the cardiac catheterization lab and other procedure areas. Further, the company provides IV Solutions; enterprise analytics and solutions; Omnicell Interface Software; Mach4 Pharma Systems Medimat, a robotic dispensing system; Omnicell SupplyX subscription software; RFID solutions; and consumable medication blister cards, packaging equipment, and ancillary products and services to institutional pharmacies. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was founded in 1992 and is headquartered in Mountain View, California.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,


The Relative Strength Index (RSI) Indicator: Does It Work?

Looking for stock market analysis and research with proves results? offers in-depth financial research with over 30years of proven results.

Omnicell's (OMCL) Portfolio Expansion Aids Amid Macro Woes

Omnicell (OMCL) accelerates its shift to cloud-based solutions and tech-enabled services through the launch of Inventory Optimization Service and Central Pharmacy Dispensing Services.

Here's Why You Should Retain Omnicell (OMCL) Stock Now

Investors are optimistic about Omnicell (OMCL) due to its technology and innovative solutions.

Here’s Why Conestoga Capital Advisors Sold Omnicell (OMCL)

Conestoga Capital Advisors, an asset management company, released its “Small Cap Strategy” third-quarter 2023 investor letter. A copy of the same can be downloaded here. The Small Cap Composite returned -6.72% net-of-fees in the third quarter, compared to the Russell 2000 Growth Index’s -7.32% return. The strategy’s outperformance was driven by positive stock selection effects, while sector […]

Omnicell, Inc. (NASDAQ:OMCL) Q3 2023 Earnings Call Transcript

Omnicell, Inc. (NASDAQ:OMCL) Q3 2023 Earnings Call Transcript November 5, 2023 Operator: Good morning, my name is Jordan, and I’ll be your conference operator today. At this time, I’d like to welcome everyone to the Omnicell Third Quarter Earnings Call. I’ll be turning the call over to Kathleen Nemeth, Senior Vice President of Investor Relations. […]

The 1-Minute Market Report November 6, 2023

For the week, the S&P 500 was up 5.9%. The S&P Top 7 stocks continue to dominate the market. Click here to read more.

Some Omnicell, Inc. (NASDAQ:OMCL) Analysts Just Made A Major Cut To Next Year's Estimates

The latest analyst coverage could presage a bad day for Omnicell, Inc. ( NASDAQ:OMCL ), with the analysts making...

Omnicell, Inc. (OMCL) Q3 2023 Earnings Call Transcript

Omnicell, Inc. (NASDAQ:NASDAQ:OMCL) Q3 2023 Earnings Conference Call November 2, 2023 8:30 AM ETCompany ParticipantsKathleen Nemeth - SVP of IRRandall Lipps...

BTIG Downgrades Omnicell (OMCL)


Wells Fargo Upgrades Omnicell (OMCL)